Navigation Links
Study shows that bedtime regularity predicts CPAP compliance
Date:5/7/2013

DARIEN, IL A new study suggests that regularity of bedtime prior to initiation of continuous positive airway pressure (CPAP) therapy is an important factor that may influence treatment compliance in adults with obstructive sleep apnea (OSA).

Results show that bedtime variability was a significant predictor of CPAP adherence, which was defined as four or more hours of treatment use per night. The odds of one-month CPAP non-adherence were 3.7 times greater for every one unit increase in habitual, or pre-treatment, bedtime variability.

"Long-term use of CPAP, such as after the first month or longer, requires regular routines that are conducive to establishing a new health behavior," said principal investigator Amy M. Sawyer, PhD, RN, assistant professor at Penn State University School of Nursing in University Park, Pa."

The research abstract was published recently in an online supplement of the journal Sleep, and Sawyer will present the findings Wednesday, June 5, in Baltimore, Md., at SLEEP 2013, the 27th annual meeting of the Associated Professional Sleep Societies LLC.

The study group comprised 97 adults with newly diagnosed OSA. Bedtime variability was derived from a seven-day sleep diary completed by each participant before CPAP treatment and one-month CPAP adherence was based on objective data collected from each CPAP device.

According to the authors, the study was not designed to test the effect of bedtime consistency on CPAP use. However, the results do suggest that regularity of bedtime may be a new opportunity for health scientists and health care providers to address the problem of non-adherence to CPAP.

"Our results suggest that CPAP use is associated with stable bedtime schedules," said Sawyer. "By stabilizing bedtime schedules, or promoting consistency in bedtime patterns and routines prior to initiating CPAP treatment, adherence may improve."

The American Academy of Sleep Medicine reports that obstructive sleep apnea is a common sleep illness affecting at least four percent of men and two percent of women. It involves repetitive episodes of complete or partial upper airway obstruction occurring during sleep despite an ongoing effort to breathe. The most effective treatment option for OSA is CPAP therapy, which helps keep the airway open by providing a stream of air through a mask that is worn during sleep.


'/>"/>

Contact: Lynn Celmer
lcelmer@aasmnet.org
630-737-9700
American Academy of Sleep Medicine
Source:Eurekalert

Related medicine news :

1. Da Vinci Robotic Surgery Lawsuit News: Bernstein Liebhard LLP Comments on New Study Evaluating Robotic Surgery Training Methods
2. Gasoline Poisonings in Kids Spike During Summer: Study
3. Sleep Woes Tied to Prostate Cancer Risk in Study
4. Some Blackboard Chalks Might Spur Allergies in Kids: Study
5. Study demonstrates that once-a-day pill offers relief from ragweed allergy symptoms
6. Study Shows Dual Targeting of HER2 and HR-positive Metastatic Breast Cancer Improves Survival Rates
7. Bel Marra Health Reports on a New Study Revealing Why Men Struggle to Figure Out Women
8. Sentimental Gifts Are the Best Mother’s Day Gifts, Study Shows
9. Study examines spiritual support for patients with advanced cancer
10. Living Long May Protect Against Early Alzheimers, Study Finds
11. Flu Vaccine Safe for Kids With Crohns, Colitis: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... Sept. 25, 2017   Montrium , an ... solutions, today—from the IQPC Trial Master Files & ... NL)—announced that EastHORN Clinical Services has selected ... and TMF management. EastHORN, a leading European contract ... to increase transparency to enable greater collaboration with ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
(Date:9/22/2017)... -- AVACEN Medical (AVACEN) announced that its CE-Marked AVACEN ... with the widespread pain associated with fibromyalgia in the ... Essex, England commented, "I had difficulty ... sleep at all, tremendous pain, with every movement sending ... AVACEN 100] enough, how this has and is helping ...
Breaking Medicine Technology: